Gene · 5341
Papers3,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal saliva omics responses to immune perturbation: a case study. | Sci Rep | 2021 | 33436912 | PubTator, text mining | PubMed |
| Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia. | Exp Hematol | 2021 | 33421548 | PubTator, text mining | PubMed |
| ALS2-related disorders in Spanish children. | Neurol Sci | 2021 | 33409823 | PubTator, text mining | PubMed |
| Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells. | Biomedicines | 2021 | 33406639 | PubTator, text mining | PubMed |
| Cdc48/Shp1 participates in dissociation of protein complexes to regulate their activity. | Curr Genet | 2021 | 33388824 | PubTator, text mining | PubMed |
| COPD-associated miR-145-5p is downregulated in early-decline FEV1 trajectories in childhood asthma. | J Allergy Clin Immunol | 2021 | 33385444 | PubTator, text mining | PubMed |
| Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis. | Oncol Lett | 2021 | 33376540 | PubTator, text mining | PubMed |
| SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia. | Cancer Gene Ther | 2021 | 33247227 | PubTator, text mining | PubMed |
| Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis. | Life Sci | 2021 | 33203523 | PubTator, text mining | PubMed |
| Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. | Leukemia | 2021 | 33168949 | PubTator, text mining | PubMed |
| Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. | Mol Cancer Res | 2021 | 33154093 | PubTator, text mining | PubMed |
| Application of quantitative transcriptomics in evaluating the ex vivo effects of per- and polyfluoroalkyl substances on Atlantic cod (Gadus morhua) ovarian physiology. | Sci Total Environ | 2021 | 33138996 | PubTator, text mining | PubMed |
| Pathophysiological significance of N-myc downstream-regulated gene 2 in cancer development through protein phosphatase 2A phosphorylation regulation. | Cancer Sci | 2021 | 33128318 | PubTator, text mining | PubMed |
| Deciphering the dual role and prognostic potential of PINK1 across cancer types. | Neural Regen Res | 2021 | 33063717 | PubTator, text mining | PubMed |
| A systematic evaluation of bioinformatics tools for identification of long noncoding RNAs. | RNA | 2021 | 33055239 | PubTator, text mining | PubMed |
| LncExpDB: an expression database of human long non-coding RNAs. | Nucleic Acids Res | 2021 | 33045751 | PubTator, text mining | PubMed |
| MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia. | Cell Stem Cell | 2021 | 32997960 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants. | Cell Mol Gastroenterol Hepatol | 2021 | 32827707 | PubTator, text mining | PubMed |
| Signaling roles of phosphoinositides in the retina. | J Lipid Res | 2021 | 32540927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5341/papers?page=36